About Us
Shandong Qidu Pharmaceutical Co., Ltd. (formerly known as Shandong Linzi Pharmaceutical Factory) was founded in 1976, which is a collective ownership enterprise. We carried out stock system reform in 1998, and our company became a limited liability company in 2004.
Our company is located at Linzi District, Zibo City, the former capital of Qi State, which is a famous city, historically and culturally. Our company is appraised as "Shandong Province High Tech Enterprise" and "Major High Item Tech Enterprise" under the National Torch Program. Moreover, our company is a leading enterprise of National Torch Project in the bio-pharmaceutical industry. We are also appraised as one of the "500 Top Pharmaceutical Industrial Enterprises" and the "10 Top Innovation of Chemical Medicine Manufacturing".
We have seven pharmacy workshops and two holding companies, one is a technology center of provincial enterprise, and the other is a blood plasma substitute R&D center of provincial engineering technology project. We mainly produce 7 series and over 100 specifications of medicine products including injection tablets and capsules, granulated medicines, medicine syrup, raw medicine materials and other related products. With large injection capacity, we can annually produce 500 million bottles (or Non-PVC bags) of the leading products. In the same industry, we rank first in Shandong Province and the third in China. "QIDU" brand is famous in Shandong.
We have perfect sales networks and quality management systems, so our products are very popular in China, and some of them are exported to West Europe, Latin America and South Asia.
Our company advocates "invigorating our factory by science and technology" and takes the way of "creation and development". We're making close cooperation with Shandong University and Shandong University of Chinese Medicine and other high educational schools and scientific and research units.
In recent years, we have received 30 certificates of new medicines of 6 series, including cardio-vascular and cerebral-vascular type, antibiotic type, anti-tumor type and liver illness, and blood plasma substitute amino acid, including Bufumai: Buflomedil Hydrochloride and Sodium Chloride injection and Buflomedil Hydrochloride and sustained release tablets, and Dinuoxin: Levofloxacin Hydrochloride and Sodium Chloride injection and tablets, Qiqong: Tropisetron Hydrochloride and Sodium Chloride injection, Hydroxyethyl Starch 20.40.130.200 Sodium Chloride injection, Compound Amino Acid injection 3AA.6AA.17AA.18AA.19AA., and other medicines. Enjoying a high brand credit, they have gain a high rate in national market.
We always insist on the concept of "honesty, cooperation, development". Medicine can improve health, and "caring for life and paying close attention to quality" is our mission and purpose. In order to seek great development, RMB 550 million will be invested in Qidu Pharmacy Scientific And Technological Estate, covering 476 acres. The first phase project will be put into operation soon. We're making cooperation with related universities and colleges and scientific and research units in new types of integrating traditional Chinese medicines, modernization items and biologic pharmacy items. The development of our company has been improved on the basis of ancestor's way and will make a new chapter. We can make greater and new contribution to strengthen motherland's medicine industry and improve human health.
Company Profile
Company Name: |
ShanDong QiDu Pharmaceutical Co.,LTD |
Country/Territory: |
China (Mainland) |
Company Address: |
No.28 Renmin east road ,Linzi district ,Zibo city,ShanDong,China 255400 |
Products/Services We Offer: |
raw material |
Industry Focus: |
Pharmaceutical Chemicals, Bio-technology Products, Herb Medicine. |
Business Type: |
Manufacturer |
No. of Employees: |
1000 - 5000 People |
Year Established: |
1976 |
Website: |
http://www.qiduyy.com.cn http://en.myitrade.com/miya0201/ |